About Cagrilintide
Cagrilintide is a long-acting synthetic analogue of amylin, a peptide hormone produced by the pancreas. It is a 37-amino-acid peptide with an intramolecular disulfide bridge and a C20 fatty diacid side chain, a modification designed to make it more stable and longer-acting than native amylin [1]. It acts at both amylin receptors and calcitonin receptors [2]. It has the molecular formula C194H312N54O59S2 and a molecular weight of approximately 4409 g/mol.
At the time of writing, cagrilintide has not been approved as a medicine by the MHRA, the FDA or any other regulator, and it remains in clinical development. The product sold here is a research compound for laboratory use only.
Related research compounds: Semaglutide (GLP-1 receptor), Tirzepatide (GIP and GLP-1 receptors) and Retatrutide (GIP, GLP-1 and glucagon receptors).
Areas of research
Published research on cagrilintide includes:
- its design and structure–activity development as a stable, lipidated, long-acting amylin analogue [1]
- studies in genetically modified mice investigating which brain amylin receptor subtypes are involved in its activity [2]
- structural studies of the amylin receptor complexes it acts at [3]
Further receptor and pathway studies are ongoing. These studies relate to an investigational substance studied under controlled conditions and are cited for scientific background only.
Product specifications
| Form |
Lyophilised (freeze-dried) powder in a sealed vial |
| Sizes |
2mg, 5mg, 10mg |
| Structure |
37-amino-acid amylin analogue with a disulfide bridge and a C20 fatty diacid side chain |
| Molecular formula |
C194H312N54O59S2 |
| Molecular weight |
approx. 4409 g/mol |
| Purity |
COA shown is for the 10mg batch. The current 10mg COA reports HPLC purity of >99.7%. |
Storage and handling
Storage & Handling — Corex Vitality™ research vials
- As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
- Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
- Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
- Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
- Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
- Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
- Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.
Compound note: Contains a Cys–Cys bridge that holds its shape: do not add reducing agents such as DTT, which would break it. Five asparagines make it less stable in solution — prepare fresh, aliquot and freeze. Test a small portion for solubility first.
For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.
Quality and testing
Cagrilintide batches we sell have a published third-party HPLC Certificate of Analysis. On Lingda reports the Client is the manufacturer/supplier; we publish the file exactly as issued. The COA shown is for the 10mg batch; no separate COA has been issued for the 2mg or 5mg sizes. You can also browse every published certificate on our COA and verification page.
Research use only
For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.
Related reading
References
- Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem. 2021. PubMed 34288673
- Carvas AO, et al. Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. EBioMedicine. 2025. PubMed 40609154
- Cao J, et al. A structural basis for amylin receptor phenotype. Science. 2022. PubMed 35324283
Reviews
There are no reviews yet.